SMASH Fully Loaded Anabolic Triggering Workout Intensifier by Axis Labs

Take only Pre-Workout, Not Daily
Skin Bursting Cell Volumizing Pump
Ramps Up Intramuscular Strength
Expands Blood Plasma Volume
Enhances Vascularity for Roadmap like Veins
Stimulates Carnosine Production to Reduce Fatigue
Increases Mental Alertness and Focus to Get you Zoned
Amplifies Energy Levels and Feelings of Well-being
Decreases Lactic Acid and Ammonia Burn
Increases Endurance, Perfect for Any Athlete
Precision Formulated for an Outstanding Taste
Flavored with Sucralose, not Aspartame
Low in Carbohydrates

Highly Active Pre-workout Intensifier

Are you tired of being instructed to choke down your pre-workout drink everyday of the month? SMASH® Fully Loaded is designed to be so powerful that you only need to take it before you train. This is a huge advantage to you in terms of ease-of-use and the longevity per container. Find out for yourself why the world's most complete pre-workout formula out performs the competition in 1/3rd less the servings.

Time to Lock and Load

Persistent deep muscle stimulation and energized workouts are the key to unlocking your body's true potential. Don't hold yourself back any more. Get Zoned, Get Pumped and Get Ready to SMASH®!

Component Breakdown

SLINGSHOT™ Plasma Endurance Infusion

This infusion is designed with one goal in mind; Pure unadulterated endurance. SMASH® is formulated with Citrulline Malate, shown to reduce lactic acid and ammonia burn. The added Beta-Alanine stimulates Carnosine production which reduces muscle fatigue while training. Additionally SMASH® is spiked with PlasmaFlo which pulls water out of extracellular (outside the muscle) space into the blood, thus enhancing the thickness and visibility of blood vessels and hydration.

Size and Strength Infusion

You may already know that creatine increases ATP (adenosine triphosphate), the body's source of intramuscular energy and strength. This is why SMASH® is powered with the world's most powerful creatine; Creatine Ethyl Ester. Creatine Ethyl Ester HCl is an exceptionally soluble creatine resulting in advanced absorption, increased bioavailability and stability.

N.O. Pump and Vascularity Infusion

Intramuscular stimulation is best ignited through Nitric Oxide Pump. SMASH® is formulated with a powerful infusion of muscle volumizing ingredients designed to take your workouts to the next level. The Nitric Oxide Pump SMASH® delivers stimulates deep muscle tissue and shuttles muscle building nutrients right where you need them.

PHIRE Energy and Focus Infusion

Training exhaustion occurs with every avid athlete. SMASH® keeps this serious problem in mind. Within the first 15 minutes of taking SMASH® you will start to feel its powerful energizing effects. Bust through training fatigue and be energized before even getting to the gym. Solid energy is key to keeping a persistent heart pumping pace. In addition, the Energy Infusion keeps you mentally focused and alert during training.

Hydrating Electrolyte Infusion

To assist in ATP production, SMASH® has been fortified with the Hydrating Electrolyte Infusion, containing key electrolytes essential for the production of creatine phosphate. These Electrolytes are also involved in the regulation of muscle force. The proper balance of the electrolytes is essential for normal function of your cells and organs which is why SMASH® is the perfect, systematically engineered formula.

As a dietary supplement, take 1 level scoop with 16oz of water 30 minutes before workout on a light to empty stomach. To avoid sleeplessness, do not take within 4 hours of bedtime.

Directions for Advanced Users: As a dietary supplement, take 1½ scoops with 20oz of water 30 minutes before workout on a light to empty stomach. To avoid sleeplessness, do not take within 4 hours of bedtime.

WARNING: KEEP OUT OF REACH OF CHILDREN. Use only as directed. Not for use by individuals under the age of 18 or elderly. Do not use if you are pregnant or nursing. Consult a medical doctor before using this or any dietary supplement, especially if you have been treated for or diagnosed with, or have a family history of any medical condition including but not limited to: a myocardial infarction (heart attack), any cardiovascular complications, central nervous system problems, genito-urinary problems, psychiatric disease, asthma, pernicious anemia, anxiety, depression, seizure disorder, stroke, difficulty urinating due to prostate enlargement, or if you are taking an MAO inhibitor or if you are using any other prescription or over-the-counter medication(s). Avoid additional consumption of caffeine or stimulants such as ephedrine, ephedra or Ma Huang, which may intensify adverse effects. Consult a medical doctor before starting any diet or exercise program.

Contact us to add your own testimonial!

1) Anomasiri W. S. Sanguanrungsirikul and P. Saichandee 2004. Low dose creatine supplementation enhances sprint phase of 400 meters swimming performance. J Med Assoc Thai 87 Suppl 2: S228-32.
2) Dangott B, Schultz E, Mozdziak PE. Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy. Int J Sports Med 2000 Jan;21(1):13-6
3) Falk D. J. K. A. Heelan J. P. Thyfault and A. J. Koch 2003. Effects of effervescent creatine ribose and glutamine supplementation on muscular strength muscular endurance and body composition. J Strength Cond Res 17(4): 810-6.
4) Kraemer W. J. and J. S. Volek 1999. Creatine supplementation. Its role in human performance. Clin Sports Med 18(3): 651-66 ix.
5) Mendes R. R. and J. Tirapegui 2002. Creatine: the nutritional supplement for exercise - current concepts. Arch Latinoam Nutr 52(2): 117-27.
6) Ronsen O. J. Sundgot-Borgen and S. Maehlum 1999. Supplement use and nutritional habits in Norwegian elite athletes. Scand J Med Sci Sports 9(1): 28-35.
7) Tarnopolsky M. A. 2000. Gender differences in metabolism; nutrition and supplements. J Sci Med Sport 3(3): 287-98.
8) Yu P. H. and Y. Deng 2000. Potential cytotoxic effect of chronic administration of creatine a nutrition supplement to augment athletic performance. Med Hypotheses 54(5): 726-8.
9) Abel T. B. Knechtle C. Perret P. Eser P. von Arx and H. Knecht. 2005. Influence of chronic supplementation of arginine aspartate in endurance athletes on performance and substrate metabolism - a randomized double-blind placebo-controlled study. Int J Sports Med 26(5): 344-9.
10) Blumenthal K. M. and E. L. Smith. 1975. Functional arginine residues involved in coenzyme binding by glutamate dehydrogenases. J Biol Chem 250(16): 6555-9.
11) Chromiak J. A. and J. Antonio. 2002. Use of amino acids as growth hormone-releasing agents by athletes. Nutrition 18(7-8): 657-61.
12) Cuisinier C. R. J. Ward M. Francaux X. Sturbois and P. de Witte. 2001. Changes in plasma and urinary taurine and amino acids in runners immediately and 24h after a marathon. Amino Acids 20(1): 13-23.
13) Djeraba A. E. Musset N. van Rooijen and P. Quere. 2002. Resistance and susceptibility to Marek's disease: nitric oxide synthase/arginase activity balance. Vet Microbiol 86(3): 229-44.
14) Ishii N. H. Ikenaga P. K. Carmines Y. Aoki Z. Ogawa T. Saruta and T. Suga. 2004. High glucose augments arginase activity and nitric oxide production in the renal cortex. Metabolism 53(7): 868-74.
15) Meneguello M. O. J. R. Mendonca A. H. Lancha Jr. and L. F. Costa Rosa. 2003. Effect of arginine ornithine and citrulline supplementation upon performance and metabolism of trained rats. Cell Biochem Funct 21(1): 85-91.
16) Ohtani M. K. Maruyama M. Sugita and K. Kobayashi. 2001. Amino acid supplementation affects hematological and biochemical parameters in elite rugby players. Biosci Biotechnol Biochem 65(9): 1970-6.
17) Ohtani M. M. Sugita and K. Maruyama. 2006. Amino acid mixture improves training efficiency in athletes. J Nutr 136(2): 538S-543S.
18) Wang M. X. D. F. Murrell C. Szabo R. F. Warren M. Sarris and G. A. Murrell. 2001. Nitric oxide in skeletal muscle: inhibition of nitric oxide synthase inhibits walking speed in rats. Nitric Oxide 5(3): 219-32.
19) Waugh WH Daeschner CW Files BA et al. 2001. Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J Natl Med Assoc; 93(10):363-71.
20) Aarts, E. M. and C. Hinnen-Bouwmans. 1972. Common properties of D-glucuronolactone and aldehyde dehydrogenase from the soluble fraction of rat liver. Biochim Biophys Acta 268(1): 21-9.
21) Alford, C., H. Cox and R. Wescott. 2001. The effects of red bull energy drink on human performance and mood. Amino Acids 21(2): 139-50.
22) Armstrong LE. 2002. Caffeine body fluid-electrolyte balance and exercise performance. Int J Sport Nutr Exerc Metab. Jun;12(2):189-206
23) Bell DG McLellan TM. 2002. Exercise endurance 1 3 and 6 h after caffeine ingestion in caffeine users and nonusers. J Appl Physiol. Oct;93(4):1227-34
24) Bergero, D., A. Assenza, A. Schiavone, G. Piccione, G. Perona and G. Caola. 2005. Amino acid concentrations in blood serum of horses performing long lasting low-intensity exercise. J Anim Physiol Anim Nutr. Berl) 89(3-6): 146-50.
25) Blomstrand, E. and B. Saltin. 1999. Effect of muscle glycogen on glucose, lactate and amino acid metabolism during exercise and recovery in human subjects. J Physiol 514. Pt 1): 293-302.
26) Chinevere, T. D., R. D. Sawyer, A. R. Creer, R. K. Conlee and A. C. Parcell. 2002. Effects of L-tyrosine and carbohydrate ingestion on endurance exercise performance. J Appl Physiol 93(5): 1590-7.
27) Davydova, N. A., A. Senkevich Iu, M. S. Belakovskii and S. V. Samratova. 1985. Catecholamine metabolism in a high-altitude environment. Kosm Biol Aviakosm Med 19(4): 60-3.
28) Dews PB O'Brien CP Bergman J. 2002. Caffeine: behavioral effects of withdrawal and related issues. Food Chem Toxicol. Sep;40(9):1257-61
29) Hespel P Op't Eijnde B Van Leemputte M. 2002. Opposite actions of caffeine and creatine on muscle relaxation time in humans. J Appl Physiol. Feb;92(2):513-8
30) Jones A. R. and J. T. Pichot. 1998. Stimulant use in sports. Am J Addict 7(4): 243-55.
31) Kuzuya, T., Y. Kanazawa, M. Kikuchi and T. Ide. 1973. Effects of D-glucuronolactone, L-gulonolactone and penitols on insulin secretion in dogs. Endocrinol Jpn 20(4): 369-74.
32) Lieberman, H. R., J. H. Georgelis, T. J. Maher and S. K. Yeghiayan. 2005. Tyrosine prevents effects of hyperthermia on behavior and increases norepinephrine. Physiol Behav 84(1): 33-8.
33) Marselos, M. and O. Hanninen. 1974. Enhancement of D-glucuronolactone and acetaldehyde dehydrogenase activities in the rat liver by inducers of drug metabolism. Biochem Pharmacol 23(10): 1457-66.
34) Medelli, J., J. Lounana and D. Hill. 2003. Variation in plasma amino acid concentrations during a cycling competition. J Sports Med Phys Fitness 43(2): 236-42.
35) Seidl, R., A. Peyrl, R. Nicham and E. Hauser. 2000. A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids 19(3-4): 635-42.
36) Tonkes, P. G. and C. A. Marsh. 1973. Substrate specificity of mammalian D-glucuronolactone dehydrogenase. Aust J Biol Sci 26(4): 839-49.
37) Varrik, E., A. Viru, V. Oopik and M. Viru. 1992. Exercise-induced catabolic responses in various muscle fibres. Can J Sport Sci 17(2): 125-8.
38) Watson J Deary I Kerr D. 2002. Central and peripheral effects of sustained caffeine use: tolerance is incomplete. Br J Clin Pharmacol. Oct;54(4):400-6